Impact of COVID-19 in Immunosuppressed Children With Neuroimmunologic Disorders

Discussion
In this cohort of children with neuroimmunologic disorders, the frequency of COVID-19 was low and not affected by immunosuppressive therapies. The main risk factors for developing COVID-19 were having cohabitants with COVID-19 and low vitamin D levels.

Source: Neurology Neuroimmunology and Neuroinflammation - November 10, 2021 Category: Neurology Authors: Olive-Cirera, G., Fonseca, E., Cantarin-Extremera, V., Vazquez-Lopez, M., Jimenez-Legido, M., Gonzalez-Alvarez, V., Ribeiro-Constante, J., Camacho-Salas, A., Marti, I., Cancho-Candela, R., Martinez-Gonzalez, M. J., Saiz, A., Armangue, T., on behalf of the Tags: Autoimmune diseases, All Pediatric, COVID-19, All Demyelinating disease (CNS) Article Source Type: research